Michael Wittlinger

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

Dominik Pretscher, Luitpold Distel, Gerhard G. Grabenbauer et al. · BMC Cancer · 2009 · 182 citations · Full text

Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer

Jens R. Laurberg, Anne Sofie Brems-Eskildsen, Iver Nordentoft et al. · British Journal of Urology · 2012 · 101 citations

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia

Michael Wittlinger, Claus Rödel, Steffen Krause et al. · Radiotherapy and Oncology · 2009 · 59 citations

Urological Research, Urology, Surgical Oncology +8

Management of Superficial Recurrences in an Irradiated Bladder After Combined-Modality Organ-Preserving Therapy

Michael Wittlinger, Dirk G. Engehausen, F. Steffen Krause et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 49 citations

Combined-modality Organ-preserving Therapy, Irradiated Bladder, Urology +8

Survivin Expression as a Predictive Marker for Local Control in Patients With High-Risk T1 Bladder Cancer Treated With Transurethral Resection and Radiochemotherapy

Felix von Römer, Gianni Capalbo, Oliver J. Ott et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 30 citations

Local Control, Urology, Surgical Oncology +7